Bioanalytical studies and assays
The company provides PK studies, biomarker testing and immunogenicity assays throughout preclinical and clinical stages.
Source: LinkedIn company description · Retrieved November 17, 2026

Anapharm Bioanalytics is a bioanalytical CRO specializing in small- and large-molecule bioanalysis.
Its team has over 30 years’ experience in method development, validation and sample analysis, supporting drug development programs. A global partner network enables outsourcing solutions for preclinical and Phase I–IV clinical trials, and bioequivalence studies for international registration.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company supports drug development programs for pharmaceutical, biotechnological and generic industries worldwide.
The company provides PK studies, biomarker testing and immunogenicity assays throughout preclinical and clinical stages.
Source: LinkedIn company description · Retrieved November 17, 2026
Its services include PK studies, biomarker testing and immunogenicity assays, using LC-MS/MS and LBA technology platforms.
Source: LinkedIn company description · Retrieved November 17, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on November 17, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 18, 2026. Directory positions use company-contact counts from separate saved list snapshots dated November 5, 2026 and November 6, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.